Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2007
05/03/2007CA2626565A1 Piperazine derivatives useful as ccr5 antagonists
05/03/2007CA2623898A1 New cyclic peptide compounds
05/02/2007EP1780285A1 Improved virus like particles (VLP) based on the small envelope protein of hepatitis B virus (HBsAg-S)
05/02/2007EP1780214A2 Combinatorial production of nucleotide and nucleoside analogues (XiTP)
05/02/2007EP1780212A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE
05/02/2007EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands
05/02/2007EP1779853A2 9a-azalides as veterinary antimicrobial agents
05/02/2007EP1779849A1 V-ATPase inhibitors for the treatment of septic shock
05/02/2007EP1778702A2 Antiviral compounds
05/02/2007EP1778653A1 Biaryl heterocyclic compounds and methods of making and using the same
05/02/2007EP1778361A1 Antimicrobial and/or antiviral composition and to methods for preparing and administering same
05/02/2007EP1778282A1 Mutated hiv nef for modulating immunity
05/02/2007EP1778272A1 Use of a combination of cyclosporin and pegylated interferons for treating hepatitis c (hcv)
05/02/2007EP1778271A2 Peptides for the treatment of herpes virus infections
05/02/2007EP1778254A2 Prodrugs activated by rna-dependent dna-polymerases
05/02/2007EP1778251A2 Nucleoside phosphonate conjugates as anti hiv agents
05/02/2007EP1778249A2 Nucleoside phosphonate conjugates as anti hiv agents
05/02/2007EP1778240A2 Dihydropteridinones for the treatment of cancer diseases
05/02/2007EP1539070B1 Antimicrobial, silver-containing wound dressing for continuous release
05/02/2007EP1501521B1 Long acting compositions comprising zidovudine and/or lamivudine
05/02/2007EP1492766B1 Improved cc-1065 analog synthesis
05/02/2007EP1492546B1 Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system
05/02/2007EP1408952B1 Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
05/02/2007EP1370256B1 Novel inhibitors of formation of advanced glycation endproducts (ages)
05/02/2007EP1365797B1 Antibodies modulating the upa/upar interaction and uses thereof
05/02/2007EP1345658B1 Methods and vaccines for providing in ovo protection against turkey rhinotracheitis
05/02/2007EP1330467B1 Modified, hydroxy-substituted aromatic structures having cytoprotective activity
05/02/2007EP1144675A4 Pharmacokinetic-based drug design tool and method
05/02/2007EP1100921B1 Streptococcus pneumoniae proteins and nucleic acid molecules
05/02/2007EP1032596B1 Lactalbumin production process
05/02/2007EP1009846B1 Alphavirus-derived vectors useful as vaccines providing protection against paramyxovirus infection
05/02/2007EP0912085B1 Precise efficacy assay methods for active agents including chemotherapeutic agents
05/02/2007CN2894699Y Film-coated tablet of norcantharidin
05/02/2007CN1956992A Anthracycline derivatives
05/02/2007CN1956971A Novel fused heterocycles and application thereof
05/02/2007CN1956961A Stable crystal form of 4-oxoquinoline compound
05/02/2007CN1956732A Antimycobacterial pharmaceutical composition comprising an antitubercular drug
05/02/2007CN1956720A Combination medication for treating HIV infection
05/02/2007CN1956712A Antiviral composition comprising p-menthane-3,8-diol
05/02/2007CN1955305A Method for preparing anthracene Ensamu bacterial
05/02/2007CN1955192A Protein for promoting erythrocyte growth factor activity and its use
05/02/2007CN1955191A New gene PPF1 of class I control infection nail forming efficiency and pathogenicity in flamentous etiological fungus and its use
05/02/2007CN1955190A Polypeptide of controlling IIIv virus fusion and its use
05/02/2007CN1955187A Roxithromycin derivate and its preparation method and medical application
05/02/2007CN1955177A LAM nucleoside derivate, its preparation method and application
05/02/2007CN1954886A Application process of pig interleukin 2 and 6 gene expression plasmid anti-infectious preparation
05/02/2007CN1954885A Preparation and application of compound pig interleukin gene anti-infections nano molecular preparation
05/02/2007CN1954884A Preparation and application of anti-infectious immunity preparation of pig interleukin 6 gene and CpG molecular fusional
05/02/2007CN1954874A Curcuma zedoary oil fat injection and preparation process
05/02/2007CN1954856A Traditional Chinese medicinal compound preparation for treating asthma and its preparation method
05/02/2007CN1954821A Traditional Chinese composite preparation for treating asthma and its preparation method
05/02/2007CN1954818A Application of phillyrin in preparation for treating endotoxemia
05/02/2007CN1954816A Quick-slow compound medicine of anti-tuberculosis
05/02/2007CN1954815A Anti-tuberculosis compound medicine quick-slow double-release preparation and its preparation method
05/02/2007CN1954809A Personal hygiene additive for preventing STD origin of viral and chlamydia
05/02/2007CN1313617C Expression vectors encoding epitopes of target-associated antigens and methods for their design
05/02/2007CN1313605C Gene recombinant fowl influenza virus D3/F-R2/6 and its construction method
05/02/2007CN1313491C Cat omega interferon and its coding gene and uses
05/02/2007CN1313489C GP thymosin alpha 1 and preparation method
05/02/2007CN1313487C Immunoreactive peptide Trpi possessing antibacterial action
05/02/2007CN1313483C Inhibitory peptide of YMDD domain of duck hepatitis-B virus polymerase protein and application thereof
05/02/2007CN1313482C Inhibition peptide of hepatatitis B virus polyzymoprotein YMDD functional region and its application
05/02/2007CN1313472C Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
05/02/2007CN1313466C 1,3,4 furodiazole carbon-penillien compound, preparation method and application
05/02/2007CN1313459C Total flavone glycoside extract of Radix scutellariae, Rodix scutellariae monomer flavone glycoside, its preparation and use
05/02/2007CN1313152C Vaccines
05/02/2007CN1313148C HSA-free formulations of interferon-Beta
05/02/2007CN1313145C Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use
05/02/2007CN1313115C Zoster treating ointment and its prepn
05/02/2007CN1313099C Carbon gas gel transfusion agent, its preparing method and its use
05/02/2007CN1313098C New use of achyranthes polysaccharide sulphate for anti Aids and immune regulation
05/02/2007CN1313088C Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
05/02/2007CN1313081C Valacycloguanosine tablet containing colloid silica
05/01/2007USRE39608 Substituted benzimidazoles and their use as PARP inhibitors
05/01/2007US7211677 3-amino-2-ethoxycarbonylpyrrole; chemical intermediate in synthesis of 3H,5H-pyrrolo[3,2-d]pyrimidin-4-one; a convergent synthesis route rather than a linear one
05/01/2007US7211659 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
05/01/2007US7211656 Using the enzymes to make polyunsaturated fatty acids; added to pharmaceutical compositions, nutritional compositions, animal feeds, cosmetics
05/01/2007US7211601 Prevention labor contraction; urogenital disorders
05/01/2007US7211598 Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
05/01/2007US7211590 Such as 2-(nitrooxy)ethyl-2-(((3-methyl-4-(2,2,2-trifluoro-ethoxy)-2 -pyridyl)methyl)sulfinyl)benzimidazolecarboxylate; kits; for treating gastrointestinal disorders/ulcers
05/01/2007US7211578 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity
05/01/2007US7211577 Water-soluble phenylpyridazine derivative and medicine containing the same
05/01/2007US7211575 Methods of treating cytokine mediated diseases
05/01/2007US7211572 Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
05/01/2007US7211570 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus or Kaposi's sarcoma-associated herpes ("KHSV")
05/01/2007US7211565 a 15 to 22-residue polypeptide analog that forms an amphipathic alpha helix in the presence of lipids; anticholesterol agents; hypercholesterolemia, cardiovascular disorders, atherosclerosis, restenosis, hypertriglyceridemia, high density lipoprotein deficiency, metabolic disorders
05/01/2007US7211420 Oxidizing limonene or pinene or a cyclic sesquiterpene, wherein said limonene, pinene or cyclic sesquiterpene is optionally substituted by an alkyl of 1 to 6 carbons or an alkenyl of 1 to 6 carbons with a mutant haem-containing P450 enzyme, wherein mutant enzyme is a mutant of a P450BM-3
05/01/2007US7211411 Human papilloma virus treatment
05/01/2007US7211404 Liver engrafting cells, assays, and uses thereof
05/01/2007US7211264 Salmonella pathogenicity island two (Spi2) double mutant for use as tool in developing vaccine for treatment and prevention of microorganismal and viral infcetions
05/01/2007US7211260 Infectious bursitis vaccine
05/01/2007CA2452032C Synergistic antimicrobial compositions and methods of inhibiting biofilm formation
05/01/2007CA2340545C Chelate compound-containing antibacterial agent for helicobacter pylori
05/01/2007CA2306963C Novel 3,6-hemiketals from the class of 9a-azalides
05/01/2007CA2191440C Treatment and prevention of helicobacter infection
05/01/2007CA2155493C Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
05/01/2007CA2086832C Hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines
04/2007
04/26/2007WO2007047405A1 Ddc compositions
04/26/2007WO2007047315A1 Amifostine dihydrate crystalline composition
04/26/2007WO2007046643A1 Composition comprising an extract of pine needle for preventing and treating animal disease caused by viruses and the use thereof